CytoReason (CYTOREASON IT)

The company develops a computational platform and machine learning models designed to simulate human disease at the cellular level. Its technology integrates multi-omics data and reconstructs cellular information from bulk tissue to provide mechanistic insights into the immune system, enabling pharmaceutical firms to identify and develop targeted therapies.